Related Experiment Video
Updated: Apr 19, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
Henry S Cheng1, Makon-Sébastien Njock1, Nadiya Khyzha1
1Toronto General Research Institute, University Health Network Toronto, ON, Canada ; Department of Laboratory Medicine and Pathobiology, University of Toronto Toronto, ON, Canada ; Heart and Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research Toronto, ON, Canada.
Vascular inflammation, driven by NF-κB signaling, contributes to atherosclerosis. MicroRNAs regulate this pathway, offering potential therapeutic targets for cardiovascular disease and aging.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Aging Research
Background:
- Cardiovascular diseases, including atherosclerosis, are major global health burdens.
- Atherosclerosis progression is linked to vascular inflammation and endothelial cell activation.
- The transcription factor NF-κB is central to endothelial inflammatory signaling, with enhanced activity during aging.
Purpose of the Study:
- To review the role of microRNAs in regulating vascular inflammation and NF-κB signaling.
- To explore the therapeutic potential of microRNA-based interventions for cardiovascular diseases.
- To discuss emerging roles of long noncoding RNAs and circulating microRNAs in vascular health.
Main Methods:
- Literature review of studies on microRNAs, NF-κB signaling, and vascular inflammation.
- Analysis of data from mouse models of vascular inflammation and atherosclerosis.
- Synthesis of current knowledge on noncoding RNA regulation in endothelial cells.
Main Results:
- Noncoding RNAs, especially microRNAs, significantly modulate the NF-κB signaling pathway in vascular inflammation.
- Dysregulation of these microRNAs is implicated in the pathogenesis of atherosclerosis.
- Aging exacerbates NF-κB activation, potentially mediated by altered noncoding RNA expression.
Conclusions:
- MicroRNAs are key regulators of vascular inflammation and NF-κB activity.
- Targeting microRNA pathways presents a promising therapeutic strategy for atherosclerosis and age-related cardiovascular disease.
- Further research into long noncoding RNAs and circulating microRNAs may reveal novel therapeutic avenues.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of Angiogenesis and Blood Supply
NF-kB-dependent Signaling Pathway
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting
lncRNA - Long Non-coding RNAs

